Literature DB >> 3840248

Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat.

Brian Milne1, Frank Cervenko, Khem Jhamandas, Christopher Loomis, Maaja Sutak.   

Abstract

The objectives of this study were to investigate the duration of analgesia and the development of tolerance following continuous intrathecal administration of morphine and norepinephrine alone, and morphine followed by norepinephrine via mini-osmotic pumps in the rat. Analgesia was assessed by the tail-flick test. In single pump experiments morphine 1 microliter (10 micrograms)/h (7 days) and 0.5 microliter (10 micrograms)/h (14 days) produced analgesia with tolerance by days 5-7. Norepinephrine 1 microliter (15 micrograms)/h (7 days) produced analgesia equivalent to that of morphine with tolerance developing by day 3. Following continuous intrathecal morphine 1 microliter (10 micrograms)/h for 5 days, norepinephrine 1 microliter (15 micrograms)/h for 7 days failed to produce a significant increase in analgesia. This was in contrast to the increase in analgesia seen when the norepinephrine infusion followed a saline infusion. Determination of the norepinephrine concentration in the solution from the osmotic pumps verified that the norepinephrine is stable for the treatment period.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840248     DOI: 10.1016/0304-3959(85)90176-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

1.  Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.

Authors:  B Milne; M Sutak; C M Cahill; K Jhamandas
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

2.  Evidence for crosstolerance to the analgesic effects between morphine and selective alpha 2-adrenoceptor agonists.

Authors:  C Post; T Archer; B G Minor
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Effects of spinal naloxone and naltrindole on the antinociceptive action of intrathecally administered dexmedetomidine.

Authors:  Y Takano; M Takano; I Sato; T L Yaksh
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

4.  A pharmacokinetic-pharmacodynamic model of tolerance to morphine analgesia during infusion in rats.

Authors:  D M Ouellet; G M Pollack
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

5.  Subarachnoid Transplant of the Human Neuronal hNT2.19 Serotonergic Cell Line Attenuates Behavioral Hypersensitivity without Affecting Motor Dysfunction after Severe Contusive Spinal Cord Injury.

Authors:  Mary J Eaton; Eva Widerström-Noga; Stacey Quintero Wolfe
Journal:  Neurol Res Int       Date:  2011-06-01

6.  Perioperative Opioid Consumption and Clinical Outcomes in Surgical Patients With a Pre-existing Opioid-Based Intrathecal Drug Delivery System.

Authors:  Ryan S D'Souza; Matthew A Warner; Oludare O Olatoye; Brendan J Langford; Danette L Bruns; Darrell R Schroeder; William D Mauck; Kalli K Schaefer; Nafisseh S Warner
Journal:  Anesth Analg       Date:  2022-01-01       Impact factor: 5.108

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.